PRESS RELEASE: REALTROMINS, Inc. Develops New Family of Medical Devices to Help Critically Ill and Hospitalized Children.


REALTROMINS, Inc (Chapel Hill, NC USA) created an advanced Predictive Analytic for Healthcare (PICU REALTROMINS) which continuously assesses the risk of mortality in critically ill children (PCT International Application No PCT/US2007/012736) (published 3/10)

Two additional medical devices have been created with our technologies to assess: 1)critically ill newborns in the Neonatal ICU (Neonatal REALTROMINS); and 2)hospitalized children outside the ICU (Pediatric Rapid Response REALTROMINS) (PCT/US2011/42416 (6/11)).

Our research team is continuing to develop additional devices for use in:
1)critically ill adults (Adult REALTROMINS); 2)hospitalized adults (Adult Rapid Response REALTROMINS); and 3)wounded combatants and disaster victims (Triage REALTROMINS).

The most important function of a pediatric intensive care unit (PICU) is to provide advanced computerized monitoring capabilities to clinicians to evaluate the clinical status of patients and to track their response to a wide range of interventions. We have integrated multiple classes of variables, such as:

A. continuous physiologic signals;
B. advanced measures of variability;
C. laboratory measures of organ function;
D. advanced measure of variability of (C);
E. demographic & diagnosis related predictors;

and analyzed them with advanced signal processing, statistical, and neural network techniques to create a real time, continuously updated, risk for mortality score in critically ill children. REALTROMINS (REAL Time Risk of Mortality and INStability) is a new advanced technology to be used by physicians to guide critically ill children back to health. REALTROMINS is being commercialized to the ICU monitoring industry (valued at $1.2 billion of sales annually) with the assistance of the 1) Office of Technology Development and 2) Carolina Entrepreneur’s Initiative at the Kenan-Flagler School of Business, both at the University of North Carolina.